Blacktrace
Design, develop and manufacture the coolest cutting-edge scientific products and technologies, and sell these via market leading brands.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor | €0.0 | round | |
* | N/A | Acquisition | |
| Total Funding | 000k | ||
| GBP | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 11 % | 32 % | (8 %) | (61 %) | 7 % | 41 % | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | 2 % | 40 % | (20 %) | (32 %) | (19 %) | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Blacktrace Group is a dynamic and fast-growing science and technology company specializing in the design, development, and manufacturing of cutting-edge scientific products and technologies. The company serves clients in various fields including chemistry, biology, nanomaterial sciences, and microfluidics. Operating in the global market, Blacktrace leverages its expertise to turn scientific discoveries into commercial products. The business model revolves around continuous innovation and the development of new products, which are sold through market-leading brands. Revenue is generated through the sale of these advanced scientific products and technologies to research institutions, laboratories, and industrial clients. The company is open to acquisition opportunities but does not actively pursue them.
Keywords: scientific products, chemistry, biology, nanomaterial sciences, microfluidics, innovation, technology, commercial products, research, laboratories, industrial clients.